Detalhe da pesquisa
1.
Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer.
Future Oncol
; 19(10): 727-736, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133230
2.
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Urol Int
; 107(6): 595-601, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36996793
3.
Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study.
Eur J Clin Pharmacol
; 78(12): 1973-1979, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266366
4.
Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group).
Turk J Med Sci
; 52(4): 1022-1032, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36326360
5.
The comparison of FOLFOX regimens with different doses of 5-FU for the adjuvant treatment of colorectal cancer: a multicenter study.
Int J Colorectal Dis
; 36(6): 1311-1319, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33586012
6.
[Clinical features of the ALK-mutant non-small cell lung cancer patients who received first-line alectinib treatment]. / Birinci basamak alektinib tedavisi alan ALK mutasyonu pozitif akciger kanseri hastalarinin klinik özelliklerinin degerlendirilmesi.
Tuberk Toraks
; 69(3): 321-327, 2021 Sep.
Artigo
em Turco
| MEDLINE | ID: mdl-34581153
7.
Low recurrence rate of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment in a real-world chronic hepatitis C patients cohort.
J Viral Hepat
; 26(6): 666-674, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30740820
8.
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases.
Sci Rep
; 14(1): 5820, 2024 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38461209
9.
Clinicopathological and survival features of neuroendocrine tumors: A retrospective analysis of 153 cases, our current remarks on a heterogeneous tumor group, and still unmet future expectations.
J Cancer Res Ther
; 19(2): 347-354, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37006071
10.
Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data.
Pancreas
; 52(4): e235-e240, 2023 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816170
11.
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
J Cancer Res Clin Oncol
; 149(11): 8243-8253, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37067546
12.
Real life experience of patients with locally advanced gastric and gastroesophageal junction adenocarcinoma treated with neoadjuvant chemotherapy: a Turkish oncology group study.
J Chemother
; 35(2): 142-149, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579894
13.
Major and minor salivary gland cancers: A multicenter retrospective study.
Head Neck
; 45(7): 1643-1653, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084179
14.
An unusual infection with long-term bevacizumab treatment for advanced nonsmall-cell lung cancer: Actinomycosis.
J Cancer Res Ther
; 18(6): 1809-1810, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36412450
15.
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.
J Cancer Res Clin Oncol
; 148(12): 3537-3546, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616728
16.
The relationship between adjuvant chemotherapy and thiol-disulfide compounds.
J Cancer Res Ther
; 18(4): 1114-1118, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36149169
17.
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.
Sci Rep
; 12(1): 16559, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192500
18.
Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group.
Medicine (Baltimore)
; 101(50): e32368, 2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36550824
19.
Trastuzumab ± Capecitabine Maintenance After the First-Line Treatment of HER2-Positive Advanced Gastric Cancer: Retrospective Observational Real-Life Data of Turkish Oncology Group.
J Gastrointest Cancer
; 53(2): 282-288, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538958
20.
First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer.
Bosn J Basic Med Sci
; 22(5): 818-825, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460397